Bokus

Paul J M Jackson – författare

Visar alla böcker från författaren Paul J M Jackson. Handla med fri frakt och snabb leverans.

3 produkter

  1. David Thurston, Paul J M Jackson - Cytotoxic Payloads for Antibody–Drug Conjugates, Inbunden. Tillgänglighet: Lägg i varukorg

    Cytotoxic Payloads for Antibody–Drug Conjugates

    Av David Thurston, Paul J M Jackson

    Inbunden, 2019

    3357 kr

    Lägg i varukorg

    Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadcyla™), brentuximab vedotin (Adcetris™), inotuzumab ozogamicin (Besponsa™), gemtuzumab ozogamicin …

  2. Paul J M Jackson, David Thurston - Cytotoxic Payloads for Antibody-Drug Conjugates, E-bok. Tillgänglighet: Lägg i varukorg

    Cytotoxic Payloads for Antibody-Drug Conjugates

    Av Paul J M Jackson, David Thurston

    E-bok, 2019

    3004 kr

    Lägg i varukorg

    Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [ i.e ., ado-trastuzumab emtansine (Kadcyla™), brentuximab vedotin (Adcetris™), inotuzumab ozogamicin (Besponsa™), gemtuzumab ozogamicin …

  3. Paul J M Jackson, David Thurston - Cytotoxic Payloads for Antibody-Drug Conjugates, E-bok. Tillgänglighet: Lägg i varukorg

    Cytotoxic Payloads for Antibody-Drug Conjugates

    Av Paul J M Jackson, David Thurston

    E-bok, 2019

    2939 kr

    Lägg i varukorg

    Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [ i.e ., ado-trastuzumab emtansine (Kadcyla™), brentuximab vedotin (Adcetris™), inotuzumab ozogamicin (Besponsa™), gemtuzumab ozogamicin …